SCM Lifescience Co., Ltd. (KOSDAQ:298060)
South Korea · Delayed Price · Currency is KRW 847.00
0.00 (0.00%)
At close: Feb 19, 2026
SCM Lifescience Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -8,238 | -12,377 | -23,961 | -22,930 | -22,519 | -9,633 |
Depreciation & Amortization | 896.89 | 859.21 | 839.44 | 1,041 | 1,136 | 1,231 |
Loss (Gain) From Sale of Assets | -1,214 | 267.05 | - | - | 0.48 | 1.38 |
Asset Writedown & Restructuring Costs | 316.79 | 65.27 | - | - | - | - |
Loss (Gain) From Sale of Investments | 1,086 | 1,086 | 59.16 | - | - | -15,229 |
Loss (Gain) on Equity Investments | - | - | 10,673 | 11,650 | 9,999 | 6,043 |
Stock-Based Compensation | -345.84 | 41.96 | 614.04 | 664.68 | -1,974 | 4,297 |
Other Operating Activities | -755.71 | -806.91 | 118.18 | -1,218 | 374.22 | 2,739 |
Change in Accounts Receivable | -518.65 | 57.61 | -100.78 | 11.17 | 1.8 | -4.2 |
Change in Inventory | 43.61 | -142.96 | -289.35 | 176.97 | -243.66 | 273.53 |
Change in Accounts Payable | -2.35 | - | - | - | - | - |
Change in Other Net Operating Assets | 339.57 | 896.71 | -88.33 | -579.09 | -178.57 | -609.09 |
Operating Cash Flow | -8,391 | -10,053 | -12,136 | -11,184 | -13,404 | -10,890 |
Capital Expenditures | -8,161 | -4,074 | -235.57 | -504.83 | -676 | -1,480 |
Sale of Property, Plant & Equipment | 16,902 | - | - | - | - | - |
Sale (Purchase) of Intangibles | -201.13 | -305.33 | -8.05 | - | - | -7.9 |
Investment in Securities | -5,931 | 6,969 | -7,265 | 16,000 | 16,957 | -23,407 |
Other Investing Activities | -2,437 | 53.42 | 498.83 | -496.86 | -489.46 | 1,238 |
Investing Cash Flow | 172.55 | 2,643 | -7,010 | 14,998 | 15,791 | -23,657 |
Short-Term Debt Issued | - | - | - | 2,000 | - | - |
Long-Term Debt Issued | - | 3,150 | - | 3,630 | - | - |
Total Debt Issued | 3,150 | 3,150 | - | 5,630 | - | - |
Short-Term Debt Repaid | - | - | -2,000 | - | - | - |
Long-Term Debt Repaid | - | -186.43 | -148.91 | -6,091 | -474.9 | -512.04 |
Total Debt Repaid | -6,963 | -186.43 | -2,149 | -6,091 | -474.9 | -512.04 |
Net Debt Issued (Repaid) | -3,813 | 2,964 | -2,149 | -460.78 | -474.9 | -512.04 |
Issuance of Common Stock | 11,962 | - | 19,333 | 674.38 | 907.7 | 32,263 |
Repurchase of Common Stock | - | - | -16.56 | - | - | - |
Other Financing Activities | -0 | 0.09 | -441.82 | -1.86 | -7.52 | -1,562 |
Financing Cash Flow | 8,149 | 2,964 | 16,725 | 211.73 | 425.29 | 30,189 |
Miscellaneous Cash Flow Adjustments | - | 0 | - | - | - | - |
Net Cash Flow | -69.79 | -4,446 | -2,421 | 4,026 | 2,813 | -4,358 |
Free Cash Flow | -16,552 | -14,127 | -12,372 | -11,689 | -14,080 | -12,370 |
Free Cash Flow Margin | -1072.73% | -1712.75% | -1778.30% | -2951.85% | -3205.28% | -3865.43% |
Free Cash Flow Per Share | -728.88 | -690.44 | -755.88 | -805.93 | -1176.70 | -1165.98 |
Cash Interest Paid | 260.93 | 222.3 | 288.38 | 204.31 | 169.73 | 217.05 |
Cash Income Tax Paid | 2.6 | 24.79 | -29.73 | 6.69 | -45.53 | -74.57 |
Levered Free Cash Flow | -12,862 | -10,030 | -8,706 | -7,677 | -9,620 | -17,089 |
Unlevered Free Cash Flow | -12,668 | -9,868 | -8,511 | -7,527 | -9,496 | -16,772 |
Change in Working Capital | -137.82 | 811.35 | -478.46 | -390.96 | -420.44 | -339.77 |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.